You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
SLENYTO is indicated for:, treatment of insomnia in children and adolescents aged 2-18 years with Autism Spectrum Disorder (ASD), and / or neurogenetic disorders with aberrant diurnal melatonin secretion and/or nocturnal awakenings, where sleep hygiene measures have been insufficient., treatment of insomnia in children and adolescents aged 6-17 years with attention-deficit hyperactivity disorder (ADHD) where sleep hygiene measures have been insufficient.,Neurogenetic disorders are those of the central and peripheral nervous systems clearly associated with a characteristic set of symptoms and signs, which are caused by molecular defects in heritable material (usually DNA). Examples include Smith-Magenis syndrome, Angelman syndrome, Rett syndrome, Tuberous sclerosis complex, and Williams syndrome.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
SLENYTO is indicated for:, treatment of insomnia in children and adolescents aged 2-18 years with Autism Spectrum Disorder (ASD), and / or neurogenetic disorders with aberrant diurnal melatonin secretion and/or nocturnal awakenings, where sleep hygiene measures have been insufficient., treatment of insomnia in children and adolescents aged 6-17 years with attention-deficit hyperactivity disorder (ADHD) where sleep hygiene measures have been insufficient.,Neurogenetic disorders are those of the central and peripheral nervous systems clearly associated with a characteristic set of symptoms and signs, which are caused by molecular defects in heritable material (usually DNA). Examples include Smith-Magenis syndrome, Angelman syndrome, Rett syndrome, Tuberous sclerosis complex, and Williams syndrome.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on June, 1 2026. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
SLENYTO is indicated for:, treatment of insomnia in children and adolescents aged 2-18 years with Autism Spectrum Disorder (ASD), and / or neurogenetic disorders with aberrant diurnal melatonin secretion and/or nocturnal awakenings, where sleep hygiene measures have been insufficient., treatment of insomnia in children and adolescents aged 6-17 years with attention-deficit hyperactivity disorder (ADHD) where sleep hygiene measures have been insufficient.,Neurogenetic disorders are those of the central and peripheral nervous systems clearly associated with a characteristic set of symptoms and signs, which are caused by molecular defects in heritable material (usually DNA). Examples include Smith-Magenis syndrome, Angelman syndrome, Rett syndrome, Tuberous sclerosis complex, and Williams syndrome.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on June, 1 2026. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
